🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting products of uncertain source.

Some professionals stated the demand for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for human use under the British medical regulations.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Content Removal

Based on TikTok, the platform has removed violative content and prohibited associated hashtags and query recommendations. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, positive testimonials and detailed guides for mixing or injecting at residence.

Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Product Details and Pricing

Within these groups, posts display black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting substances they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen individuals injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to potentially serious medical dangers”.